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INTRODUCTION
Gamma-aminobutyric acid (GABA) is the major inhibitory
neurotransmitter in the brain. Neurons producing GABA are located
in almost all parts of the central nervous system (CNS) and are
highly variable in their morphology, gene expression and projection
patterns.
GABAergic neurons are found in several regions of the midbrain.
They are thought to operate both as local inhibitory interneurons and
as projection neurons with targets elsewhere in the brain. GABAergic
neurons are abundant in the dorsal superior colliculi and
periaquaductal gray matter, where they are involved in multiple
processes, including saccadic eye movements, nociception and
defensive behavior (Behbehani et al., 1990; Kaneda et al., 2008). In
the ventral midbrain, GABAergic neurons are thought to regulate the
activity of the dopaminergic (DA) neurons in the substantia nigra pars
compacta and ventral tegmental area (VTA) (Laviolette and van der
Kooy, 2004; Tepper and Lee, 2007). In addition to controlling the DA
neurons, GABAergic neurons located in the VTA and substantia
nigra pars reticulata (SNpr) send their axons to other nuclei in the
midbrain, prefrontal cortex and other limbic areas (Laviolette et al.,
2004; Fields et al., 2007). Thus, midbrain GABAergic neurons are
crucial for neural processes such as the regulation of voluntary and
involuntary movements, mood, motivation and addiction.
Despite the functional importance of the midbrain GABAergic
neurons, their development remains poorly understood. There
appear to be both similarities and differences in the mechanisms that
control the development of GABAergic neurons in distinct brain
regions. Proliferative progenitor cells of the GABAergic neurons are
located in the ventricular zone of both ventral and dorsal midbrain
(Tsunekawa et al., 2005). This is in contrast to the forebrain, where
the GABAergic neurons are generated in ventral neuroepithelium
and reach the cortex by dorsal tangential migration. As in ventral
forebrain and other regions of GABAergic neurogenesis, the
proneural bHLH transcription factor Ascl1 (Mash1) is expressed in
the ventricular zone of the midbrain and plays an important role in
GABAergic neuron development (Horton et al., 1999; Casarosa et
al., 1999; Miyoshi et al., 2004; Mizuguchi et al., 2006). Helt
(Heslike, Megane, Mgn) is a bHLH-Orange family transcription
factor that is coexpressed with Ascl1 in the midbrain ventricular
zone (Miyoshi et al., 2004). Mice lacking Helt function show
impaired development of midbrain GABAergic neurons, especially
in the dorsal region (Guimera et al., 2006; Nakatani et al., 2007).
Furthermore, Helt has been shown to regulate the GABAergic
versus glutamatergic neuron identity by repressing the proneural
genes Ngn1 and Ngn2 (Neurog1 and Neurog2), which in turn
promote glutamatergic neuron development (Nakatani et al., 2007).
In addition to genes controlling the proliferation, identity and
neurogenesis of the ventricular zone progenitor cells, studies of other
parts of the CNS have revealed transcription factors that are
activated only in the post-mitotic neural precursors. Some of these
factors do not regulate the neuronal differentiation process itself, but
are needed to select a particular neuronal phenotype from among
distinct alternatives and are therefore called selector genes. The
bHLH transcription factor Ptf1a appears to act as a selector of the
GABAergic, as opposed to glutamatergic, fate in the spinal cord and
cerebellum (Glasgow et al., 2005; Hoshino et al., 2005; Cheng et al.,
2005). However, no such selector gene for the midbrain GABAergic
neurons has been identified so far.
Gata2 and Gata3 are related C4 zinc-finger transcription factors.
They are involved in the development of several organs and tissues,
and have been extensively studied, especially in the hematopoietic
system (Tsai et al., 1994). In the developing CNS, Gata2 and Gata3
are expressed in similar patterns in distinct brain regions and Gata2
is often required for the expression of Gata3 (Nardelli et al., 1999).
Gata2 has been suggested to play a role in the correct development
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of cranial motoneurons (Nardelli et al., 1999), rostral serotonergic
neurons in rhombomere 1 (Craven et al., 2004) and spinal V2
interneurons (Zhou et al., 2000; Karunaratne et al., 2002). However,
studies of Gata2 function in neuronal development have been
hampered by the early death of Gata2-null embryos.
We show here that Gata2 is specifically expressed in the
developing midbrain GABAergic neurons as they exit the cell cycle
and differentiate. Using conditional mutagenesis and ectopic
expression experiments, we show that Gata2 acts as an essential
post-mitotic selector gene of the GABAergic identity without
affecting proliferating neural progenitors or early neurogenic
processes in the embryonic midbrain. We further map the
GABAergic progenitor domains in the mouse embryonic midbrain
and demonstrate region-specific interactions between Helt and
Gata2. Interestingly, our results suggest that GABAergic neurons
associated with the ventral DA nuclei in the midbrain use distinct
regulatory mechanisms for their development.
MATERIALS AND METHODS
Mice
En1Cre (Kimmel et al., 2000), HeltKO [MgntZ (Guimera et al., 2006)] and
Ascl1KO [Mash1null (Guillemot et al., 1993)] alleles have been described
previously. The conditional Gata2 allele (Gata2flox) will be described
elsewhere (M.H., K.L. and M.S., unpublished). Briefly, in Gata2flox, exons
1-3, encoding the N-terminal half of Gata2, are flanked by loxP sites. Their
recombination by Cre recombinase is expected to produce a null allele of
Gata2. Gata2cko embryos were generated from En1Cre/+; Gata2flox/+ 
Gata2flox/flox mouse crosses. For staging, the day of vaginal plug was counted
as embryonic day 0.5 (E0.5). For BrdU-incorporation analysis, pregnant
females were given an intraperitoneal injection of BrdU (3 mg/100 g body
weight) 1-2 hours before dissecting the embryos. All experiments were
approved by the Committee of Experimental Animal Research of the
University of Helsinki, Finland.
In ovo electroporation
In ovo electroporation was performed at Hamburger-Hamilton stage (HH)
14-16. For Gata2 overexpression, pAdRSVGata2HA plasmid (El Wakil et
al., 2006) was microinjected into the embryonic midbrain (third ventricle)
together with the EGFP expression vector pEGFP-N3 (Clontech). As a
control, embryos were electroporated with the EGFP expression vector only.
Electroporation was performed at 20 mV; 10  20 millisecond pulses were
applied with 500 millisecond intervals. The embryos were harvested 24
or 48 hours later (at HH20-22) and EGFP-expressing embryos were
embedded in paraffin for analysis. Five embryos electroporated with
pAdRSVGata2HA and two control embryos were analyzed.
In situ mRNA hybridization and immunohistochemistry
Whole-mount mRNA in situ hybridization (ISH) analysis of E10.5 embryos
was performed by a modified protocol (Henrique et al., 1995) using a
digoxigenin-labeled antisense Gata2 cRNA probe. For ISH and
immunohistochemistry (IHC) on sections, embryos or embryonic brains
were fixed in 4% paraformaldehyde (PFA) at room temperature for 1-5 days.
Samples were dehydrated and mounted into paraffin. Sections were cut at 5
μm, and adjacent sections were collected on separate slides for parallel
stainings. mRNA ISH analyses on paraffin sections were performed as
described (Wilkinson and Green, 1990) using 35S- or digoxigenin-labeled
cRNA probes. Mouse cDNA probes used for ISH analysis were: Gata2,
Gata3 (Lillevali et al., 2004), Ascl1, Fev (Pet1), Ngn2 (Jukkola et al., 2006),
Gad1 (Gad67), Helt, Slc17a6 (Vglut2), Pitx2 (Guimera et al., 2006), Pou4f1
(gift from Siew-Lan Ang, National Institute of Medical Research, London,
UK), Nkx2-2 (IMAGE clone 480100), Pax6 (gift from P. Gruss, Max-
Planck-Institute for Biophysical Chemistry, Goettingen, Germany), Isl1 (gift
from V. Pachnis, National Institute of Medical Research, London, UK) and
Lmx1b (gift from H. Simon, Interdisciplinary Centre for Neuroscience,
Universität, Heidelberg, Germany). In addition, probes for chicken Gata3
(Lillevali et al., 2007), Ngn2 (Matter-Sadzinski et al., 2001), Slc17a6 and
Gad1 (Cheng et al., 2004) were used.
IHC was performed as described (Kala et al., 2008). The following
antibodies were used: guinea pig anti-Heslike (Helt, 1:500; gift from R.
Kageyama, Institute for Virus Research, Kyoto University, Japan), goat anti-
HA probe (Santa Cruz sc-805-G, 1:500) and anti-Olig2 (Neuromics
GT15132, 1:200), mouse anti-BrdU (GE Healthcare RPN20AB, 1:400),
anti-HuC/D (Molecular Probes A21271, 1:500), anti-Lim1/2 [Lhx1,
Developmental Studies Hybridoma Bank (DSHB) 4F2, 1:10], anti-Mash1
(Ascl1, BD Biosciences 556604, 1:200), anti-Nkx2-2 (DSHB 74.5A5,
1:250), anti-Nkx6-1 (DSHB F55A10, 1:500) and anti-Pax6 (DSHB PAX6,
1:100), rabbit anti-caspase 3 active (R&D Systems AF835, 1:500), anti-
Gata2 (Santa Cruz sc-9008, 1:250), anti-5-HT (Immunostar 20080, 1:5000),
anti-p57 (NeoMarkers RB-1637-P0, 1:500), anti-phospho-histone H3
(Upstate 06-570, 1:500), anti-Sox2 (Millipore AB5603, 1:500) and anti-TH
(Millipore AB152, 1:500).
For combined ISH and IHC, additional primary antibodies were added
together with the anti-DIG-POD Fab fragments (Roche). The TSA
Fluorescence Palette System (PerkinElmer) was used to visualize ISH
signal. Detailed ISH and IHC protocols are available upon request.
Microscopy and quantification
Whole-mount stainings were visualized with a Leica MZFLIII microscope
and photographed using an Olympus DP50-CU camera. Stainings on
paraffin sections were visualized with an Olympus AX70 microscope and
photographed using an Olympus DP70 camera. Images were processed and
assembled using Adobe Photoshop software. Red pseudo-color images
representing the ISH results were produced by replacing the white signal in
dark-field images with red, and overlaying the resulting image with the
respective bright-field image.
Confocal images were acquired using the Leica TCS SP5 confocal system
and LAS-AF software. Confocal stacks and images were processed and
deconvoluted using Imaris 6.1 (Bitplane) and AutoQuantX (AutoQuant)
software.
For quantification, cells were counted only from the Helt expression
domain. For BrdU incorporation, cells from whole neuroepithelium were
counted. For phospho-histone H3 expression, only cells lining the ventricle
were counted. A standard Student’s t-test was used for comparing the mean
values of the data sets.
RESULTS
Gata2 and Gata3 are expressed in the regions of
GABAergic neurogenesis in the embryonic mouse
midbrain
Gata2 and Gata3 are expressed in the developing mouse midbrain,
but they have not been associated with any particular neuronal
lineage (Nardelli et al., 1999; Zhou et al., 2000). We compared the
pattern of expression of Gata2 and Gata3 with that of the neural
subtype markers Lmx1b (DA neurons), Isl1 (Islet1, motoneurons),
Pou4f1 (glutamatergic neurons) and glutamic acid decarboxylase 1
(Gad1, GABAergic neurons) in the mouse midbrain from E10.5 to
E12.5 by in situ hybridization (ISH) (Fig. 1; see Fig. S1 in the
supplementary material). Throughout development, expression of
both Gata2 and Gata3 coincided with that of Gad1 and was flanked
by Pou4f1 expression domains (Fig. 1A-L). Strong Gata2 and
Gata3 ISH signal was detected in the intermediate and marginal
zones. Weaker expression of Gata2, but no expression of Gata3, was
also observed in the ventricular zone. We detected no Gata2
transcripts in Lmx1b- or Isl1-expressing regions in the mouse
midbrain (Fig. 1A-C,M-R). From E12.5 onwards, scattered
expression of Gata2, Gata3 and Gad1 appeared in the dorsal
midbrain (Fig. 1C,F,I) correlating with the timing of GABAergic
neurogenesis in this region (Tsunekawa et al., 2005).
In order to understand in detail the identity of cells expressing
Gata2, we compared the expression of Gata2 protein with
homeodomain transcription factors expressed in progenitor and
precursor cells of the developing midbrain. Lhx1 (Lim1) is
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expressed in post-mitotic precursor cells of all midbrain
GABAergic neurons in domains m1-m5, as well as in glutamatergic
neurons of the red nucleus in m6 [for a description of the midbrain
domains m1-m7, see Fig. 8 and Nakatani et al. (Nakatani et al.,
2007)]. At E12.5, immunohistochemistry (IHC) demonstrated
coexpression of Gata2 and Lhx1 in the intermediate zone cells of
domains m3-m5, where GABAergic neurons are produced at this
stage of development (Fig. 1S,T). Nkx6-1 and Nkx2-2 are
expressed in specific subsets of GABAergic neuron progenitors and
precursors (Nakatani et al., 2007). Colocalization of Gata2 and
Nkx6-1 was observed in the basal ventricular zone of domains m5
and m3 (Fig. 1U; see Fig. S1A in the supplementary material). Also,
some progenitor/precursor cells in m4 expressed both Nkx2-2 and
Gata2 (Fig. 1V; see Fig. S1B in the supplementary material). Thus,
we found Gata2 expression in all the midbrain regions that give rise
to GABAergic neurons.
We observed a small area that was negative for Gata2, Gata3 and
Gad1 expression in the m4 domain expressing Nkx2-2 (Fig.
1B,C,E,F,H,I). Pax6 is also expressed near the Nkx2-2-positive
region in the developing midbrain (Ahsan et al., 2007). By
combining ISH and IHC, we showed that Pax6 is expressed in a
subset of Nkx2-2-positive cells in the ventral m4 domain at E11.5
(see Fig. S1C in the supplementary material). Interestingly, no
Gata2 protein was detected in the Pax6-expressing cells (Fig. 1W).
Next, we analyzed the neurotransmitter identities in the m4
marginal zone. Both ISH and IHC demonstrated that the Pax6-
positive cells express Slc17a6 [vesicular glutamate transporter 2
(Vglut2)] and are negative for Gad1 (see Fig. S1D-G in the
supplementary material). Thus, the m4 domain can be further
divided into a GABAergic Gata2-positive dorsal part (m4-D) and
a glutamatergic Pax6-positive ventral part (m4-V). In addition to
the m4-V, putative glial progenitors expressing Olig2 were also
devoid of Gata2 expression at E12.5 (Fig. 1X). In conclusion, the
expression of Gata2 mRNA and protein correlates with the spatial
and temporal appearance of the GABAergic neuron lineage in the
developing mouse midbrain.
Gata2 is activated in the developing GABAergic
neurons as the progenitor cells exit the cell cycle
and start to differentiate
To gain insight to the possible role of Gata2 in GABAergic
neurogenesis, we compared the expression of the bHLH transcription
factors Ascl1 and Helt with that of Gata2 in the m3-m5 ventricular
zone by IHC (Fig. 2A-C). As reported, extensive coexpression of
Ascl1 and Helt was observed in the progenitors (Fig. 2D) (Miyoshi
et al., 2004). Notably, we observed coexpression mostly at the apical
and medial regions of the ventricular zone, while on the basal side,
the Ascl1-expressing nuclei were negative for Helt. Also, Gata2 was
detected in the Ascl1-positive cells (Fig. 2F), but, in contrast to Helt,
its expression was detected primarily in the nuclei on the basal side
of the ventricular zone (Fig. 2E,F). In the medial ventricular zone,
nuclei coexpressing Helt and Gata2 were detected (Fig. 2E). The
gradual upregulation of Gata2 in the Ascl1- and Helt-expressing
cells/nuclei as they move further away from the ventricular surface
suggested that Gata2 expression might be switched on in the
GABAergic progenitors that are about to exit the ventricular zone. To
confirm this, we analyzed the Gata2-expressing cells for expression
of HuC/D (Elavl3/4), a marker of post-mitotic neurons, and for DNA
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Fig. 1. Gata2 and Gata3 expression in embryonic mouse
midbrain compared with expression of neural subtype
markers. (A-R) In situ hybridization (ISH) with Gata2, Gata3,
Gad1, Pou4f1, Isl1 and Lmx1b probes on coronal sections of
wild-type embryos. The embryonic stages are indicated at the
top of each column. Black arrows point to the negative areas
within the expression domains of Gata2, Gata3 and Gad1.
(S-X) Co-immunostaining for Gata2 (red) and Lhx1, Nkx6-1,
Nkx2-2, Pax6 or Olig2 (green). The boxed area in S indicates
the region enlarged in T-X. White arrows indicate examples of
Gata2 and Nkx6-1 (U), and Gata2 and Nkx2-2 (V),
coexpressing cells. Scale bars: 100μm.
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synthesis as measured by BrdU incorporation. Representing mostly
intermediate zone cells, a large proportion of Gata2-expressing cells
were also positive for HuC/D (Fig. 2G, arrows). In addition, HuC/D-
negative, yet Gata2-expressing cells were observed in the ventricular
zone (Fig. 2G, arrowheads). However, these Gata2-expressing nuclei
did not incorporate BrdU during a short labeling pulse (Fig. 2H).
Together, our results show that Gata2 expression is switched on in
GABAergic progenitors as they become post-mitotic precursor cells
and start to differentiate.
Helt promotes Gata2 expression
Because of the sequential expression of Helt and Gata2 in the
GABAergic progenitor and precursor cells, we asked whether Helt
is required for Gata2 activation. We analyzed Helt-null embryos
[MgntZ/tZ (Guimera et al., 2006)] for Gata2 mRNA expression.
Interestingly, Gata2 was undetectable in E11.5 and E13.5 HeltKO
midbrain, except for the ventral-most GABAergic neurons (Fig.
3A,B; data not shown). The remaining Gata2 expression correlated
with Gad1 expression (Fig. 3C,D, arrow). We detected no Gata2 or
Gad1 expression in the dorsal midbrain of the E13.5 HeltKO embryos
(data not shown). At the same time, Ascl1 expression was unaffected
by Helt inactivation (Fig. 3E,F), as shown previously (Nakatani et
al., 2007).
To test whether Ascl1 also regulates Gata2 expression, we
analyzed E11.5 Ascl1-null mutants (Guillemot et al., 1993). In these
embryos, expansion of the Sox2- and Helt-expressing layer
suggested a failure in cell cycle exit of GABAergic progenitors (Fig.
3I-L). However, Gata2 was still expressed in regions where post-
mitotic precursors were produced (Fig. 3G,H). Altogether, except
for the ventral-most GABAergic precursors, activation of Gata2
requires Helt, but does not require Ascl1.
Conditional Gata2 inactivation leads to specific
loss of GABAergic neuron precursors in the
embryonic midbrain
To study the role of Gata2 in GABAergic neuron development, we
inactivated Gata2 in the mouse midbrain and rhombomere 1 (r1) by
crossing mice carrying a conditional allele of Gata2 (M.H., K.L. and
M.S., unpublished) with those carrying the En1Cre allele (Kimmel et
al., 2000). In the En1Cre mouse strain, the Cre recombinase activity
has been demonstrated as early as the 5-10 somite stage (Chi et al.,
2003; Trokovic et al., 2003), well before the expression of Gata2 in
the midbrain-r1 region. In the En1Cre; Gata2flox/flox (Gata2cko) mice,
no Gata2 expression was detected in the midbrain-r1 region at E10.5
or E11.5 (see Fig. S2 in the supplementary material).
Interestingly, we observed a complete loss of Gad1, Gad2 and
Gata3 expression in Gata2cko midbrain at E11.5 and E13.5 (Fig.
4A,A,B,B,E,F; see Fig. S3A-H in the supplementary material). No
GABAergic neuron precursors were detected at any dorsoventral or
anteroposterior level in the midbrain of Gata2cko mutants at these
stages. These results suggested an early and absolute requirement
for Gata2 in midbrain GABAergic neuron development that cannot
be compensated for over time.
Unaltered progenitor cell proliferation,
patterning, neurogenesis, survival and cell cycle
exit in the Gata2cko mutant midbrain
Next, we investigated which steps in midbrain GABAergic neuron
development are affected by the loss of Gata2. Despite the loss of
GABAergic precursors, there were no overt anatomical defects in
the embryonic Gata2cko mutant midbrain. Nevertheless, we
analyzed in more detail the properties of the proliferative progenitor
cells that give rise to the midbrain GABAergic precursors. In the
Gata2cko mutants, the ventricular zone progenitors still expressed
Sox2 and there was no difference in the thickness of the Sox2-
positive ventricular zone or HuC/D-positive marginal zone
compared with the wild type (see Fig. S4A-E in the supplementary
material). Consistently, we detected no major changes in the
numbers of phospho-histone H3-positive mitotic nuclei or BrdU-
incorporating S-phase nuclei in the GABAergic progenitor domain
of the Gata2cko mutants (see Fig. S4F-K in the supplementary
material). Also, we observed no increase in apoptotic cell numbers
(see Fig. S4N,O in the supplementary material). Thus, we conclude
that the loss of GABAergic neurons is not due to impaired
proliferation or survival of their progenitors.
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Fig. 2. Expression of Gata2 during GABAergic differentiation.
(A-F) Relationship between Gata2, Helt and Ascl1 expression in
GABAergic progenitors analyzed by immunohistochemical co-staining.
The boxed area in A-C is enlarged in D-H. Nuclei at the apical (Ap) side
of the ventricular zone abundantly coexpress Helt (D) and Ascl1 (D).
Nuclei near the basal (Ba) side of the ventricular zone coexpress Ascl1
(F) and Gata2 (F). Nuclei coexpressing Helt (E) and Gata2 (E) are
detected mostly in the medial ventricular zone. (G-H) Analysis of post-
mitotic differentiation of the Gata2-positive cells. Both HuC/D-positive
(arrows) and -negative (arrowheads) cells expressing Gata2 can be
detected (G). Ventricular zone cells expressing Gata2 do not
incorporate BrdU during a 1.5-hour labeling pulse (H). Scale bars:
100μm.
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We then characterized patterning and neurogenesis in the
GABAergic neuron progenitors of the Gata2cko mutants. All the
analyzed transcription factors, including Nkx6-1, Nkx2-2 and Pax7,
involved in the patterning of the ventricular zone progenitor cell
layer were correctly expressed (Fig. 4K,L,Q-T; data not shown). The
transcription factors showing normal expression in the progenitors
also included Ascl1 and Helt (Fig. 4M,N,I,J), as well as Ngn2, which
has been suggested to be involved in glutamatergic neurogenesis in
the midbrain (Fig. 4O,P). In addition, we observed no change in the
expression of p57 (Cdkn1c), a cell cycle inhibitor upregulated at
withdrawal from the cell cycle, demonstrating that Gata2-deficient
progenitors are still able to exit from the cell cycle and become post-
mitotic precursors (see Fig. S4L,M in the supplementary material).
Our results suggest that progenitor cell patterning and neurogenic
cell cycle exit are not disturbed by the loss of Gata2 in the midbrain.
GABAergic-to-glutamatergic fate transformation
of the post-mitotic precursors in the midbrain of
Gata2cko mutants
Since the GABAergic progenitors were unaffected in Gata2cko
midbrain, we analyzed the characteristics of the post-mitotic
neuronal precursors. In contrast to the normal appearance of the
GABAergic progenitor cell layer, all the post-mitotic derivatives of
these cells had transdifferentiated into a glutamatergic phenotype in
the Gata2cko midbrain. In E11.5 Gata2cko mutants, the expression of
Slc17a6 expanded to cover the entire marginal zone, including the
regions where the GABAergic precursors should reside (Fig.
4C,C,D,D). In addition, we detected ectopic expression of Pou4f1
in the post-mitotic cells of the m3 domain (Fig. 4G,H), indicating
that in the absence of Gata2, differentiating neurons in m3 could
have acquired a glutamatergic neuron fate typical for the adjacent
m2. Ventrally in the m5 domain, Nkx6-1 is downregulated during
post-mitotic differentiation of wild-type GABAergic precursor cells.
We noticed continued Nkx6-1 expression in the m5 marginal zone
in the E11.5 Gata2cko mutants, similar to that in the neighboring
glutamatergic domain m6 (Fig. 4S,T). However, the fate
transformation is incomplete because Pou4f1, another marker of m6,
was not activated in the mutant m5 domain (data not shown).
In addition to Gad1, Gad2 and Gata3, other genes
characteristic of the post-mitotic GABAergic neuron precursors
were also downregulated in the Gata2cko mutants. At E11.5, Lhx1
was downregulated in the m5 and m3 domains, but persisted in
the m4 (Fig. 4U,V). In addition, the glutamatergic domain m6
continued to express Lhx1, as expected. Although some Lhx1-
positive cells appeared in the marginal zone of m5 (Fig. 4V), they
might have originated from neighboring domains, as the
intermediate zone of m5 is negative for Lhx1 but both m4 and m6
continued to express it. The m4 domain also appeared to retain its
identity as judged by continued Nkx2-2 expression and lack of
Pou4f1 expression in the Gata2cko mutants (Fig. 4K,L,G,H).
Despite continued Lhx1 and Nkx2-2 expression, there was
complete loss of GABAergic markers and uniform glutamatergic
marker gene expression in the m4 domain of the mutants. This
discrepancy could be explained by an uncoupling of regional
patterning and neurotransmitter selection, as suggested by
Nakatani et al. (Nakatani et al., 2007). Alternatively, because m4
produces both GABAergic and glutamatergic precursors (see
above), there could be a transformation within m4 whereby the
GABAergic m4 precursors (m4-D) assume an identity of
glutamatergic m4 precursors (m4-V, Fig. 4A,C). To test this, we
analyzed Pax6 expression in the Gata2cko mutants. Ectopic Pax6-
expressing cells were observed in the m4-D region (Fig. 4W,X)
indicating that in the absence of Gata2, the whole m4 domain
acquired a fate similar to m4-V glutamatergic neurons. Thus,
Gata2 is essential for activating gene expression patterns typical
for post-mitotic GABAergic precursor cells in the midbrain.
Without Gata2, the precursor cells appear to adopt a phenotype
resembling, but not necessarily identical to, that of the adjacent
glutamatergic regions.
Ectopic Gata2 is sufficient to induce GABAergic
differentiation in embryonic chicken midbrain
We next examined whether Gata2 alone is sufficient to switch
on the GABAergic differentiation pathway. For this, we
employed ectopic expression of Gata2 in chicken embryos. First,
we studied the pattern of endogenous chicken Gata2 (cGata2)
expression and its relationship with the development of
GABAergic neurons in chick midbrain. As in the mouse embryo
at the equivalent stage, expression of Helt, Gata2, cGata3, Lhx1
and cGad1 coincided in the ventrolateral chick midbrain, and was
flanked by cNgn2- and cSlc17a6-expressing glutamatergic
domains at HH20-22 and HH22-24 (Fig. 5A-I). Similar to in
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Fig. 3. Gata2 and GABAergic marker gene
expression in Helt-null and Ascl1-null mouse
embryos. (A-F) ISH analysis of Gata2, Gad1 and
Ascl1 expression on coronal sections of E11.5 WT
and HeltKO midbrains. Arrows indicate the ventral
population of GABAergic neurons that still develop
in the Helt-null mutants.
(G-J) Immunohistochemistry (IHC) of Gata2 and Helt
expression in E11.5 wild-type (WT) and Ascl1-null
embryos. (K,L) Sox2 and HuC/D co-IHC
demonstrates delayed neurogenesis in the Ascl1-null
embryo, especially in the m3 GABAergic domain.
The borders of the m3 region were deduced from
Nkx2-2 IHC signal on adjacent sections. Scale bar:
100μm.
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E12.5 mouse midbrain, we observed scattered cGad1 expression
in the chick dorsal midbrain at a slightly later stage (HH22-24,
Fig. 5H). Unlike in the mouse, dorsal cNgn2 expression was
detected primarily in the marginal zone and might mark the
differentiated glutamatergic neurons rather than their progenitors
(Fig. 5C). However, our results demonstrate that overall, the
pattern, timing and regulatory mechanisms of midbrain
GABAergic neuron production are likely to be conserved between
these two species.
We then used tissue electroporation to overexpress Gata2 in the
dorsal chick midbrain, which normally gives rise to both
GABAergic and glutamatergic neurons. Abundant Lhx1-, cGata3-
and cGad1-positive cells were observed in the regions expressing
ectopic Gata2, 24 and 48 hours after electroporation (Fig. 5J-
M,O,P; data not shown). No ectopic expression of GABAergic
markers was observed on the control side not expressing ectopic
Gata2 or in embryos electroporated with the GFP-expressing
control vector only (data not shown). At the same time, expression
of cNgn2 was reduced dorsally (Fig. 5N,Q). Given the pattern of
cNgn2 expression (see above), this might reflect a specific failure
in the production of glutamatergic neurons, rather than a defect
in their ventricular zone progenitors. However, general
developmental retardation of the Gata2-electroporated tissue
might also contribute to cNgn2 downregulation. In all, these results
suggest that Gata2 is sufficient to induce a GABAergic phenotype,
as judged by cGad1, cGata3 and Lhx1 expression, in the midbrain
neuroepithelium.
Normal development of GABAergic, but loss of
serotonergic, neurons in rhombomere 1 of
Gata2cko mutants
To study GABAergic neuron development in r1, we analyzed E11.5
wild-type and Gata2cko mouse embryos for Gata3 and Gad1
expression. In striking contrast to the midbrain, where both genes
were completely downregulated, Gata3 and Gad1 expression in the
GABAergic precursors of r1 was not altered in the mutant (Fig.
6A,B,E,F). Thus, Gata2 is dispensable for the early development of
GABAergic neurons in r1.
Previous studies have suggested a role for Gata2 and Gata3 in the
development of other neuronal populations in the midbrain-r1
region, including cranial motoneurons and serotonergic neurons
(Nardelli et al., 1999; Craven et al., 2004; Pattyn et al., 2004).
Consistent with the pattern of Gata2 expression, we observed no
defects in the cranial Isl1-expressing motoneurons of nIII and nIV
in the Gata2cko mutants (see Fig. S3I,J in the supplementary
material). Thus, the nIII/nIV defects in the Gata2-null mutants were
likely to be secondary to other developmental abnormalities in these
embryos. By contrast, almost no serotonin (5-HT)-, Lmx1b- or Fev
(Pet1)-positive serotonergic neurons were detected in r1 of E11.5
and E13.5 Gata2cko mutants (Fig. 6C,D,G-L). Despite its continued
expression in the GABAergic precursors, Gata3 was specifically
downregulated in the serotonergic neuron precursors in r1 (Fig.
6A,B). These results confirm that Gata2 is required for the
development of rostral serotonergic neurons. They also further
demonstrate the loss of Gata2 function in r1 of Gata2cko mutants.
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Fig. 4. Fate transformation of midbrain GABAergic
neuron precursors in Gata2cko mouse embryos. (A-P) ISH
analysis of Gad1, Slc17a6, Gata3, Pou4f1, Helt, Nkx2-2,
Ascl1 and Ngn2 expression on coronal sections of E11.5
wild-type (WT) and Gata2cko midbrains. (A-D) Higher
magnification views from the GABAergic neurogenesis
domain. Black arrows point to the small group of Slc17a6-
expressing glutamatergic neurons in m4 (C,C) surrounded
by Gad1-expressing GABAergic neurons (A,A) in WT
embryos. (Q-X) IHC analysis of transcription factors Nkx6-1,
Lhx1 and Pax6 in the m3-m5 domains of E11.5 WT and
Gata2cko midbrain. The borders of the m4 domain (S-X) were
deduced from the borders of Nkx2-2 ISH or IHC signal on
adjacent sections. The ventral border of m5 was deduced
from the ventral border of Helt expression. The border
between m3 and m1-2 (W) was deduced from the ventral
border of Pou4f1 IHC on an adjacent section. White arrows
(W,X) point to the dorsal part of m4 (m4-D). Scale bars:
100μm.
D
E
V
E
LO
P
M
E
N
T
Analysis of midbrain GABAergic neuron
subpopulations in perinatal Gata2cko mutants
demonstrates differential requirements for Gata2
To study whether the cells with the transformed neurotransmitter
identity contribute to the maturing brain, we analyzed Gata2cko
mutants shortly before birth. At E17.5 and E18.5, the gross brain
morphology of the Gata2cko mutants was similar to that of the wild
type. In sagittal sections, we observed loss of expression of the
GABAergic markers Gad1, Gata3 and Pitx2 in the Gata2cko
midbrain, in both the dorsal and ventral brain regions (see Fig. S5 in
the supplementary material). By contrast, abundant expression of
GABAergic marker genes was detected in r1. Thus, consistent with
the loss of GABAergic precursor cells in the midbrain at earlier
stages of development, inactivation of Gata2 leads into a specific
loss of GABAergic neurons in the perinatal midbrain but not in r1.
To examine the development of the GABAergic neurons in the
ventral midbrain, we performed ISH with Gad1 and Slc17a6 probes
and IHC with anti-tyrosine hydroxylase (TH) antibodies on adjacent
coronal sections of E18.5 embryos. Loss of Gad1 and Gata3 with
concomitant upregulation of Slc17a6 expression was observed in
most regions of the midbrain (Fig. 7A-H; data not shown). Thus, the
cells with the transformed neurotransmitter phenotype were still able
to survive in the maturing brain. Strikingly, Gad1 and Gata3
expression in the ventrally located VTA and SNpr was unaltered. No
increase in Slc17a6 expression was observed in these nuclei either.
Therefore, unlike in the rest of the midbrain, GABAergic neurons
associated with the ventral DA nuclei appear normal in the Gata2cko
mutants.
To test the hypothesis that the GABAergic neurons of VTA and
SNpr were derived from the midbrain neuroepithelium late in
development, we analyzed Gad1 and Gata3 expression in the
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Fig. 5. Induction of GABAergic differentiation in chick embryonic
midbrain by ectopic Gata2. (A-I) The expression patterns of Helt
(ISH), cGad1 (ISH), cNgn2 (ISH), Gata2 (IHC), cGata3 (ISH), Lhx1 (IHC)
and cSlc17a6 (ISH) in coronal sections of E3.5 (A-F) and E4 (G-I)
embryonic chick midbrain (c, chicken). Arrows in C point to cNgn
expression in the marginal zone of dorsal midbrain. Similar to in mouse
midbrain, a gap was observed in ventrolateral cGad1 expression
(arrowhead in H). Scattered cGad1 expression appears in the dorsal
midbrain by E4 (arrows in H). (J-Q) Electroporation of Gata2-HA
expression vector into chick dorsal midbrain. Expression of the
electroporated Gata2 is detected by anti-HA antibody (J,O). Expression
of cGad1 (M,P), cGata3 (L) and cNgn2 (N,Q) in the electroporated area
was detected by ISH. Induction of Lhx1 was detected by IHC (K).
Arrowheads (J-N) mark the electroporated area expressing ectopic
Gata2. Red arrows (O-Q) point to the cells that express ectopic Gata2
(HA-positive). Scale bars: 100μm.
Fig. 6. Development of r1 GABAergic and serotonergic neurons
in Gata2cko mouse embryos. ISH with Gata3 (A,B) and Gad1 (E,F)
probes on adjacent coronal sections of E11.5 wild-type (WT) and
Gata2cko embryos. Midbrain (mb) and rhombomere 1 (r1) regions are
indicated. The arrowhead points to Gata3 expression in the
serotonergic neuron precursors (A). This Gata3 expression domain is
lost in the Gata2cko mutants (arrowhead in B). Anti-serotonin (5-HT) IHC
on coronal sections of E11.5 WT (I) and Gata2cko (J) embryos. Analysis
of the serotonergic neuron markers Lmx1b (C,D, ISH), Fev (G,H, ISH)
and 5-HT (K,L, IHC) on adjacent coronal sections of E13.5 WT and
Gata2cko mutants. In I-L, higher magnification views from the r1 area
are presented. Scale bars: 100μm.
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ventral midbrain at E13.5 and E15.5, after the neurogenic period of
this brain region (Altman and Bayer, 1981). Few Gad1- or Gata3-
expressing cells were detected at E15.5 in the VTA-SNpr area of
wild-type or Gata2cko embryos (Fig. 7I-L,M-P; see Fig. S3 in the
supplementary material). Thus, GABAergic neurons associated with
the DA nuclei appear late in development.
DISCUSSION
Despite their importance in multiple aspects of behavior (Behbehani,
1995; Fields et al., 2007; Brandao et al., 2008), development of the
midbrain GABAergic neurons is poorly understood. Here, we
mapped the regions of the embryonic midbrain that give rise to
GABAergic neurons. We identified Gata2 as the first post-mitotic
selector gene required for GABAergic identity in the midbrain.
Finally, our results demonstrate differences in the regulatory
pathways and developmental history of the GABAergic neurons in
the midbrain-r1 region.
Gata2 marks regions of midbrain GABAergic
neurogenesis
A useful dorsoventral fate map of the developing mouse midbrain
was recently presented by Nakatani et al. (Nakatani et al., 2007). We
detected Gata2 and Gata3 expression in all midbrain domains where
GABAergic neurons are produced. Our studies suggest a further
refinement to the map of Nakatani et al. We propose that the Nkx2-
2-positive m4 domain gives rise to both GABAergic and
glutamatergic neurons, the latter being negative for Gata2 and
positive for Pax6 expression (Fig. 8A). In the future, it will be
important to further define the mature brain structures to which these
neural progenitor and precursor subpopulations contribute.
In the ventricular zone, the pattern of colocalization of Ascl1, Helt
and Gata2 suggests that during their maturation, the Ascl1+ Helt+
progenitors turn into Ascl1+ Gata2+ precursors. Consistent with this,
inactivation of Helt resulted in a dramatic reduction in Gata2
expression. Our results thus suggest that Gata2 expression is
activated in a Helt-dependent fashion as the neural progenitor cells
turn into post-mitotic GABAergic neuron precursors and leave the
ventricular zone. The ventral m5 domain appears to be an exception,
as here Helt was not essential for Gata2 expression (Fig. 8B).
Regulation of Gata2 expression by an as yet unidentified
mechanism in m5 is likely to explain the more severe phenotype of
Gata2cko, as compared with Helt, mutants.
Gata2 is a selector gene for GABAergic neuron
identity of the post-mitotic midbrain precursors
Gata2 has been proposed to inhibit neural progenitor cell
proliferation and promote post-mitotic differentiation, a model
consistent with its pattern of expression (El Wakil et al., 2006).
However, our results suggest that there are no marked changes in
embryonic brain morphology and layering, progenitor proliferation,
or neurogenic cell cycle exit in conditional Gata2 mutants. Thus,
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Fig. 8. Model for patterning and neurotransmitter identity
determination in the midbrain. (A) Patterns of gene expression in
the ventricular zone proliferative progenitors and post-mitotic
precursors in the midbrain of wild-type (WT) and Gata2cko mouse
embryos. The m4 domain is divided into dorsal (D) and ventral (V) parts.
(B) Model of the transcription factor functions regulating GABAergic
neurogenesis. Cell cycle exit of GABAergic progenitors is primarily
regulated by Ascl1, whereas the neurotransmitter identity is
independently controlled by sequential functions of Helt and Gata2. In
m5, Helt is not essential for Gata2 expression, which may be activated
by additional mechanisms.
Fig. 7. Analysis of midbrain GABAergic neurons in Gata2cko
mouse mutants at late embryonic stages. (A-H) IHC analysis of
tyrosine hydroxylase (TH) and ISH with Gad1, Gata3 and Slc17a6
probes on adjacent coronal sections of E18.5 wild-type (WT) and
Gata2cko midbrains. (I-P) TH, Gad1, Gata3 and Slc17a6 expression on
adjacent coronal sections of E15.5 WT and Gata2cko midbrains. SN,
substantia nigra; SNpr, substantia nigra pars reticulata; VTA, ventral
tegmental area. The dashed line delineates the TH-positive SNpr-VTA
area. Scale bars: 100μm. D
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although Gata2 may still contribute to the cell cycle exit of
neuronal progenitors, it is dispensable in this respect at least in the
midbrain.
By contrast, the Gata2 mutant neural precursors in the midbrain
appear to undergo a complete cell fate transformation. Several
genes, the expression of which is normally activated in the post-
mitotic GABAergic precursors, failed to be expressed in the Gata2
mutants. In addition, Nkx6-1, the expression of which is normally
downregulated upon GABAergic differentiation in the m5 domain,
continued to be expressed in the conditional Gata2 mutants. Instead
of the GABAergic phenotype, the Gata2-deficient midbrain
precursor cells activate expression of glutamatergic marker genes.
In the Gata2 mutants, Slc17a6 expression was observed throughout
the midbrain, whereas Pou4f1 expression was not ectopically
activated in m4. By contrast, expression of Pax6 expanded in the m4
domain of Gata2 mutants. As we showed that Pax6 is specifically
expressed in glutamatergic precursors in m4, these results together
suggest that in the conditional Gata2 mutants, the identity of m4 is
retained but the GABAergic m4 precursors switch to a glutamatergic
fate. Also, in other parts of the midbrain, the Gata2-deficient
precursors still have regional characteristics despite the
transformation of their neurotransmitter identity.
Importantly, all the observed changes in gene expression take
place in the post-mitotic precursors and neurons in the intermediate
and marginal zones, whereas the proliferative progenitor cells and
proneural gene expression in the ventricular zone are unaffected.
This is in a clear contrast to the function of Helt in the ventricular
zone, which has been shown to support GABAergic neurogenesis
partly by repressing Ngn2 expression in the progenitors and thereby
glutamatergic neuron production (Nakatani et al., 2007). In addition
to repressing Ngn2, Helt activates GABAergic gene expression
(Miyoshi et al., 2004; Guimera et al., 2006; Nakatani et al., 2007),
and Gata2 appears to be important for this function. Thus, the
expression and function of Gata2 in the midbrain are analogous to
those of the bHLH transcription factor Ptf1a, which acts as a post-
mitotic selector gene of the GABAergic identity in the developing
cerebellum and spinal cord (Glasgow et al., 2005; Hoshino et al.,
2005; Mizuguchi et al., 2006).
Developmental diversity of the midbrain
GABAergic neurons
In the perinatal Gata2 mutants, all the midbrain GABAergic neuron
subpopulations were transformed to a glutamatergic phenotype,
except for the GABAergic neurons associated with the DA neurons
in the VTA and SNpr. This was highly unexpected because no
GABAergic precursor cells were found at any dorsoventral level of
the midbrain at the earlier stages of development. There are at least
three possible explanations for this. Firstly, there could be
incomplete recombination of the Gata2flox allele by En1Cre. We find
this unlikely because we could not see any Gata2 transcripts or
protein in the Gata2cko mutants analyzed at several stages. Also, no
evidence for mosaic inactivation of Gata2 was observed in VTA,
SNpr, or other regions of the midbrain. Secondly, the remaining
GABAergic neurons could be born in a region of the midbrain that
does not require Gata2 and was missed in our analysis. We cannot
completely rule out this possibility, but nor is there any evidence for
it, as no Gad1- or Gata3-positive cells were observed at any
anteroposterior or dorsoventral level of the mutant midbrain at
E11.5-15.5. Finally, the GABAergic neurons of the VTA and SNpr
could be derived from neuroectoderm outside the midbrain. The late
appearance of the VTA and SNpr GABAergic neurons (~E15.5) and
their strikingly normal development in the Gata2cko mutants are
consistent with this hypothesis. Possible sources of the VTA and
SNpr GABAergic neurons include r1 and the diencephalon.
However, cell lineage-tracing experiments are needed to
unambiguously determine the origin of these ventral-most
GABAergic neurons.
Gata2 is dispensable for GABAergic, but essential
for serotonergic, neuron development in
rhombomere 1
Similar to in the midbrain, Gata2 and Gata3 are expressed in the
GABAergic precursors of r1. Strikingly, however, we observed
abundant GABAergic neurons in r1 of the Gata2 conditional mutants,
despite the complete loss of Gata2 in this brain region. Interestingly,
the hindbrain GABAergic precursors continued to express Gata3.
This suggests that Gata3 expression is, perhaps, not directly regulated
by Gata2 in the GABAergic precursors in r1. Analyses of Gata3
mutants and, possibly, Gata2; Gata3 double mutants, are needed to
determine whether Gata3 can possibly compensate for the loss of
Gata2 specifically in the r1 GABAergic precursor cells.
The development of rostral serotonergic neurons has also been
shown to be regulated by Gata2. Craven et al. used explant cultures
of Gata2-null mutant neuroepithelium to demonstrate a
requirement for Gata2 for the differentiation of serotonin-positive
cells in r1 (Craven et al., 2004). Consistent with this, our results
show loss of serotonergic neurons in the conditional Gata2 mutants.
In contrast to the Gata2 mutant explant cultures, our results suggest
that loss of Gata2 also leads to downregulation of Gata3 in the
serotonergic neuron precursors. This discrepancy might be
explained by distorted tissue architecture of the cultured explants
and by the continued expression of Gata3 in the nearby GABAergic
precursors in r1. It will be of interest to determine whether Gata2
also acts as a post-mitotic selector gene in the serotonergic neuron
lineage, similar to its role in the developing midbrain GABAergic
neuron precursors.
Conclusion
GABAergic versus glutamatergic neuron identity appears to be
regulated by different genetic cascades in different regions of the
CNS. Here we show specific requirement for the transcription factor
Gata2 as a cell-fate selector, and locate it in the gene hierarchy
regulating development of the GABAergic neurons in the midbrain
(Fig. 8B). Our study also further elucidates how regional identities
are generated in the distinct midbrain GABAergic neuron
subpopulations. Understanding the development, molecular identity
and functional characteristics of these diverse neurons might lead to
better diagnostics and treatment of several forms of neurological and
psychiatric disease.
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